Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs VLTO✓SelectedUSD · VLTOGSK vs VLTO performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs VLTO

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+58.4%
VLTO return
+59.1%
Excess return
-0.7%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioVLTOExcessAlpha
1D-0.1%+1.7%-1.8%-0.4%
7D-1.3%+1.9%-3.2%-1.6%
30D+2.7%+19.1%-16.3%-0.4%
3M+2.7%+23.3%-20.6%-1.0%
6M+3.3%+42.2%-38.9%-2.3%
YTD+6.5%+21.1%-14.6%+2.8%
1Y+10.7%+22.5%-11.8%+6.6%
3Y+64.4%+72.1%-7.7%+50.9%
All+58.4%+59.1%-0.7%+49.1%

Cumulative growth

Daily Returns

Daily percentage return beside VLTO.

Daily Out/Under-Performance

Portfolio return minus VLTO return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × VLTO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded VLTO wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling